Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06700408
PHASE2

RCT for the Chinese Medicine in Treating Hypercholesterolemia

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This is a randomized, double-blind, placebo-controlled clinical trial. Eligible subjects will randomized into a treatment group or placebo group. They will receive either Chinese medicine granules or placebo granules for 8 weeks followed by a 4-week observation period. The primary outcome would be the percent change in Low-density lipoprotein cholesterol levels (LDL-C) after treatment.

Official title: Efficacy and Safety of Dachaihu Decoction Combined Erzhiwan With Variation for the Treatment of Hypercholesterolemia: A Parallel, Randomized, Double-blinded, Placebo-controlled Trial

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2025-01

Completion Date

2027-04

Last Updated

2024-11-22

Healthy Volunteers

No

Interventions

DRUG

Dachaihu Decoction combined Erzhiwan with variation

Chinese medicine granules

OTHER

Placebo granules

Placebo granules